老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Guided Therapeutics, Inc.

0.2740
0.0000
成交量：- -
成交额：- -
市值：2,290.62万
市盈率：-0.95
高：0.2740
开：0.2740
低：0.2740
收：0.2740
52周最高：0.3220
52周最低：0.0644
股本：8,359.92万
流通股本：2,793.01万
量比：- -
换手率：- -
股息：- -
股息率：- -
每股收益(TTM):-0.2881
每股收益(LYR):-0.0372
净资产收益率：43.94%
总资产收益率：-129.56%
市净率：-2.99
市盈率(LYR):-7.36

数据加载中...

总览公司新闻公告
2021/06/10

重要事件披露

8-K - Current report
2021/05/21

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/07

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/11/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/05

[修订]季度报告

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
2020/10/13

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/08

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/09/16

重要事件披露

8-K - Current report
2020/09/10

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/08/20

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/07/07

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/18

重要事件披露

8-K - Current report
2020/04/20

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/31

重要事件披露

8-K - Current report
2020/03/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/02/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2019/07/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2019/05/08

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2019/04/03

重要事件披露

8-K - Current report
2018/11/15

重要事件披露

8-K - Current report
更多